PMID: 9182675Jun 16, 1997Paper

HLA-A2.1-restricted education and cytolytic activity of CD8(+) T lymphocytes from beta2 microglobulin (beta2m) HLA-A2.1 monochain transgenic H-2Db beta2m double knockout mice

The Journal of Experimental Medicine
S PascoloB Pérarnau

Abstract

Three different HLA-A2.1 monochains were engineered in which either the human or mouse beta2-microglobulin (beta2m) is covalently linked to the NH2 terminus of the heavy chain by a 15- amino acid long peptide: HHH, entirely human, HHD, with the mouse H-2Db alpha3, transmembrane, and cytoplasmic domains, and MHD, homologous to HHD but linked to the mouse beta2mb. The cell surface expression and immunological capacities of the three monochains were compared with transfected cells, and the selected HHD construct was introduced by transgenesis in H-2Db-/- beta2m-/- double knockout mice. Expression of this monochain restores a sizable peripheral CD8(+) T cell repertoire essentially educated on the transgenic human molecule. Consequently, infected HHD, H-2Db-/- beta2m-/- mice generate only HLA-A2.1-restricted CD8(+) CTL responses against influenza A and vaccinia viruses. Interestingly, the CTL response to influenza A virus is mostly, if not exclusively, directed to the 58-66 matrix peptide which is the HLA-A2.1-restricted immunodominant epitope in humans. Such mice might constitute a versatile animal model for the study of HLA-A2.1-restricted CTL responses of vaccine interest.

References

Dec 1, 1992·Proceedings of the National Academy of Sciences of the United States of America·R GlasK Kärre
May 1, 1990·European Journal of Immunology·F KievitsP Ivanyi
Jan 1, 1991·Annual Review of Immunology·B Arnold, G J Hämmerling
Jun 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·H Le MouellicP Brûlet
Aug 2, 1990·Nature·H G LjunggrenK Kärre
Sep 1, 1989·European Journal of Immunology·H EpsteinN Holmes
Jan 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·F KievitsP Ivanyi
Aug 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·O DillG J Hämmerling
Oct 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·H AllenR Flavell
Nov 11, 1982·Nucleic Acids Research·F G GrosveldR A Flavell
Apr 29, 1983·Journal of Immunological Methods·M F SaronJ C Guillon
May 10, 1994·Proceedings of the National Academy of Sciences of the United States of America·P MountfordA Smith
Jan 14, 1994·Cell·K A HogquistF R Carbone
Jan 9, 1996·Proceedings of the National Academy of Sciences of the United States of America·K ToshitaniW F Bodmer

❮ Previous
Next ❯

Citations

Nov 11, 1999·European Journal of Immunology·K GrigoriadouF A Lemonnier
Oct 18, 2002·Biopolymers·Roshni SundaramPravin T P Kaumaya
Apr 20, 2006·Cancer Immunology, Immunotherapy : CII·Pedro M S AlvesKostas Kosmatopoulos
Nov 12, 2009·Cancer Immunology, Immunotherapy : CII·Eftychia LekkaConstantin N Baxevanis
Oct 24, 2013·Cancer Immunology, Immunotherapy : CII·Haydn Thomas KissickMohamed Simo Arredouani
Mar 6, 2008·Medical Microbiology and Immunology·Véronique MerssemanSabine Reyda
Jun 10, 2010·Journal of Neuroimmune Pharmacology : the Official Journal of the Society on NeuroImmune Pharmacology·Airi HaruiMichael D Roth
May 1, 2008·Current Diabetes Reports·Klaus Pechhold, Kerstin Koczwara
Sep 27, 2003·Journal of Neuroimmunology·Anne PlonquetPierre Langlade-Demoyen
Jul 27, 2002·Journal of Biotechnology·P Moingeon
Mar 12, 2002·Virus Research·François A Lemonnier
Aug 10, 2000·Nature Biotechnology·P De BerardinisJ Guardiola
Aug 10, 2010·Nature Medicine·Liang-Ping LiThomas Blankenstein
Mar 22, 2007·Molecular Therapy : the Journal of the American Society of Gene Therapy·Maria Candela IglesiasPierre Charneau
Oct 10, 2007·Molecular Therapy : the Journal of the American Society of Gene Therapy·Aintzane ZabaletaPablo Sarobe
Mar 26, 2008·Proceedings of the National Academy of Sciences of the United States of America·Pål JohansenThomas M Kündig
Jul 10, 2010·Proceedings of the National Academy of Sciences of the United States of America·Leonard D ShultzFumihiko Ishikawa
Jul 18, 2012·Proceedings of the National Academy of Sciences of the United States of America·Lijin LiWilliam E Gillanders
Jan 9, 2003·Proceedings of the National Academy of Sciences of the United States of America·Ingo DrexlerGerd Sutter
Aug 26, 1998·The Journal of Experimental Medicine·T Miyazaki, F A Lemonnier
Apr 6, 2005·The Journal of Experimental Medicine·Sofia JohanssonPetter Höglund
Jun 14, 2006·The Journal of Experimental Medicine·Yi HaoAntonio A Freitas
Aug 22, 2007·The Journal of Experimental Medicine·Wolfgang KastenmullerIngo Drexler

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.